A phase II, multicenter, study for newly diagnosed glioblastomas using boron neutron capture therapy, additional X-ray treatment and chemotherapy
Phase 2
- Conditions
- ewly-diagnosed glioblastoma
- Registration Number
- JPRN-UMIN000002385
- Lead Sponsor
- Dept. of Neurosurgery, Osaka Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have been treated with chemotherapy or radiotherapy. 2) Female patients in definitive or possible pregnancy or in breast-feeding. 3) Patients with phenylketonuria. 4) Patients with grade III or IV in NYHA classification. 5) Patients with cerebrospinal fluid dissemination. 6) Other patients whose participation in the present study is considered inappropriate by a Principal Investigator or Clinical Investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival (OS)
- Secondary Outcome Measures
Name Time Method Tumor response Objective Response Rate (ORR) Disease Control Rate (DCR) Adverse event